SVG Potential Indication Could Bring A Glow To Brachytherapy Contender
This article was originally published in The Gray Sheet
Executive Summary
The solid beta radiation source balloon technology employed by Radiance Medical Systems' RDX radiation delivery catheter will present an advantage over competing intravascular brachytherapy systems in treating restenotic saphenous vein grafts (SVG), according to the Irvine, California firm.
You may also be interested in...
Novoste Parrying Drug-Coated Stents With Planned Indications For Beta-Cath
Novoste will rely on supplemental indications unaddressed by drug-coated stent developers to increase adoption of its Beta-Cath vascular brachytherapy system.
Novoste Parrying Drug-Coated Stents With Planned Indications For Beta-Cath
Novoste will rely on supplemental indications unaddressed by drug-coated stent developers to increase adoption of its Beta-Cath vascular brachytherapy system.
NRC Brachytherapy Regs Go Beyond FDA To Restrict Physician Off-Label Use
The Nuclear Regulatory Commission's involvement in the regulation of vascular brachytherapy devices will restrict off-label use by physicians to investigational device exemption research and procedures cleared by the agency for compassionate use.